KYNBHealthcareNano-Cap

KYNTRA BIO, INC. Insider Trading Activity

Every SEC Form 4 insider transaction reported for KYNTRA BIO, INC. (KYNB), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are KYNB insiders buying or selling?

KYNTRA BIO, INC. insiders reported 9 open-market buys ($1.5M) and 162 sells ($98.2M) across 171 Form 4 filings — a net selling position of $96.7M.

Source: SEC EDGAR Form 4

Key Statistics (as of May 19, 2026)

Total Form 4 filings
171
SEC EDGAR
Insider filers
22
Insider buys (9)
$1.5M
Insider sells (162)
$98.2M

Insider sentiment

Net selling

Net insider flow of $96.7M in net selling. 1 insider buy in the last 90 days.

Recent KYNB insider transactions

DateInsiderRoleTypeSharesPriceValue
May 19, 2026Thane WettigCEOPurchase2.8K$7.09$19.9K
May 18, 2026Thane WettigCEOSale2.8K$7.09$19.9K
Nov 17, 2025Thane WettigCEOPurchase3.7K$9.12$33.7K
Jul 2, 2025James A SchoeneckDirectorPurchase23.6K$5.07$119.5K
Mar 25, 2025Thane WettigCEOPurchase145.0K$0.35$50.7K
Mar 24, 2025James A SchoeneckDirectorPurchase300.0K$0.35$105.0K
Jun 13, 2024Deyaa AdibChief Medical OfficerPurchase22.1K$1.17$25.9K
Mar 11, 2024Thane WettigCEOPurchase50.0K$1.91$95.5K
Sep 7, 2023Jeffrey William HendersonDirectorSale2.0K$1.03$2.1K
Aug 8, 2023Jeffrey William HendersonDirectorSale2.0K$1.91$3.8K
Jul 14, 2023Jeffrey William HendersonDirectorSale2.0K$2.69$5.4K
Jul 10, 2023Enrique A ConternoChief Executive OfficerSale1.9K$2.80$5.3K
Jun 26, 2023Thane WettigChief Commercial OfficerSale791$16.53$13.1K
Jun 22, 2023Thane WettigChief Commercial OfficerSale1.8K$17.04$30.0K
Jun 16, 2023Christine ChungSVP, China OperationsSale12.5K$17.19$214.9K
Jun 9, 2023Benjamin CravattDirectorSale3.9K$17.17$67.7K
Jun 9, 2023Aoife BrennanDirectorSale4.7K$17.19$81.4K
Jun 9, 2023Suzanne BlaugDirectorSale8.5K$17.20$146.6K
Jun 9, 2023Maykin HoDirectorSale8.5K$17.44$148.6K
Jun 9, 2023Jeffrey L EdwardsDirectorSale7.9K$17.19$135.6K
Jun 9, 2023Jeffrey William HendersonDirectorSale7.0K$17.46$122.2K
Jun 9, 2023James A SchoeneckDirectorSale7.1K$18.03$128.0K
Jun 9, 2023Thane WettigChief Commercial OfficerSale1.8K$17.04$30.0K
Jun 9, 2023Juan GrahamChief Financial OfficerSale1.8K$16.99$30.3K
Jun 9, 2023Christine ChungSVP, China OperationsSale3.6K$17.04$61.9K

Showing the 25 most recent of 171 Form 4 filings for KYNTRA BIO, INC..

Most active KYNB insiders

  • Thomas B Neff31 filings
  • Kalevi Kurkijarvi24 filings
  • Pat Cotroneo19 filings
  • Christine Chung17 filings
  • Thane Wettig13 filings

Ask anything about KYNB insider activity

Use Trabud's AI agent to query KYNTRA BIO, INC.'s Form 4 history in plain English — "Show me KYNB CEO purchases this year" or compare it against any other ticker.

Open the AI agent

KYNB insider trading FAQ

Are KYNTRA BIO, INC. insiders buying or selling?

Across 171 SEC Form 4 filings, KYNTRA BIO, INC. (KYNB) insiders reported 9 open-market purchases totaling $1.5M and 162 sales totaling $98.2M. That is a net selling position of $96.7M.

How many insiders trade KYNB stock?

22 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for KYNTRA BIO, INC.. The most recent filing was accepted on May 19, 2026.

Where does Trabud get KYNB insider trading data?

All KYNB insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content